The global vertebroplasty and kyphoplasty devices market is set for steady expansion, registering a compound annual growth rate (CAGR) of 4.4% from 2022 to 2032. The increasing demand for these ...

Needham & Company LLC reissued their buy rating on shares of Stryker (NYSE:SYK – Free Report) in a report released on ...

Bird flu outbreaks have wiped out millions of hens in the US, leading to an acute egg shortage. On social media, tens of thousands of people have complained about egg shelves sitting empty at their ...

Stryker continues charming analysts like a med-tech Casanova, with Needham & Company LLC reaffirming their “buy” rating and a bullish $442 price target. Analysts expect a 19.02% upside, following a ...

After landing a commitment from 2026 receiver Dylan Wester on Friday, the Pitt Panthers quickly added another pledge. On ...